Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients.
BACKGROUND
Neuron specific enolase (NSE) has been proven effective in predicting neurological outcome after cardiac arrest with a current cut off recommendation of 33 microg/l. However, most of the corresponding studies were conducted before the introduction of mild therapeutic hypothermia (MTH). Therefore we conducted a study investigating the association between NSE and neurological outcome in patients treated with MTH.


METHODS
In this prospective observational cohort study the data of patients after cardiac arrest receiving MTH (n = 97) were consecutively collected and compared with a retrospective non-hypothermia (NH) group (n = 133). Serum NSE was measured 72 hours after admission to ICU. Neurological outcome was classified according to the Pittsburgh cerebral performance category (CPC 1 to 5) at ICU discharge.


RESULTS
NSE serum levels were significantly lower under MTH compared to NH in univariate analysis. However, in a linear regression model NSE was affected significantly by time to return of spontaneous circulation (ROSC) and ventricular fibrillation rhythm but not by MTH. The model for neurological outcome identified NSE, NSE*MTH (interaction) as well as time to ROSC as significant predictors. Receiver Operating Characteristic (ROC) analysis revealed a higher cutoff value for unfavourable outcome (CPC 3 to 5) with a specificity of 100% in the hypothermia group (78.9 microg/l) compared to the NH group (26.9 microg/l).


CONCLUSIONS
Recommended cutoff levels for NSE 72 hours after ROSC do not reliably predict poor neurological outcome in cardiac arrest patients treated with MTH. Prospective multicentre trials are required to re-evaluate NSE cutoff values for the prediction of neurological outcome in patients treated with MTH.
Steffen
Ingo G
IG
Department of Nephrology and Medical Intensive Care Medicine, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburgerplatz 1, Berlin, Germany. ingo.steffen@charite.de
Hasper
Dietrich
D
Ploner
Christoph J
CJ
Schefold
Joerg C
JC
Dietz
Ekkehart
E
Martens
Frank
F
Nee
Jens
J
Krueger
Anne
A
Jörres
Achim
A
Storm
Christian
C
D000368:Aged; D015331:Cohort Studies; D005260:Female; D006323:Heart Arrest / Q000097:blood / Q000150:complications / Q000628:therapy*; D006801:Humans; D007036:Hypothermia, Induced / Q000009:adverse effects* / Q000379:methods; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care / Q000379:methods*; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D011446:Prospective Studies; D012372:ROC Curve; D012151:Resuscitation
D010751:Phosphopyruvate Hydratase
Resuscitation. 2009 Jul;80(7):784-9
19467754
Lancet. 1975 Mar 1;1(7905):480-4
46957
Crit Care Med. 1997 Jul;25(7):1133-8
9233737
Stroke. 1999 Aug;30(8):1598-603
10436107
Neurology. 2006 Jul 25;67(2):203-10
16864809
Stroke. 2003 Dec;34(12):2881-6
14631087
Eur Heart J. 2007 Jan;28(1):52-8
17060343
Resuscitation. 2009 Oct;80(10):1119-23
19631442
Neurology. 2006 Jan 10;66(1):62-8
16401847
Resuscitation. 2009 Feb;80(2):165-70
18954930
Neurology. 1999 Mar 10;52(4):746-9
10078721
Resuscitation. 2001 May;49(2):183-91
11382525
Intensive Care Med. 2003 Feb;29(2):189-95
12594583
Crit Care Med. 2007 Apr;35(4):1041-7
17334257
Resuscitation. 2005 Apr;65(1):49-55
15797275
Acta Anaesthesiol Scand. 2009 Aug;53(7):926-34
19549271
Resuscitation. 2009 Jun;80(6):658-61
19362767
Resuscitation. 2006 Apr;69(1):29-32
16517042
Crit Care. 2008;12(3):R78
18554414
Scand J Trauma Resusc Emerg Med. 2008 Sep 15;16:9
18957071
J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):610-5
8971110
Neurocrit Care. 2009 Dec;11(3):338-44
19588273
Clin Neurol Neurosurg. 2006 Sep;108(6):558-63
16457947